Latest & greatest articles for adhd

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on adhd or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on adhd and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

ADHD

ADHD (or Attention deficit hyperactivity disorder) is a neurodevelopmental type mental disorder. It is characterised two main categories of two types of behavioural problems:

  • inattentiveness
  • hyperactivity and impulsiveness

Most people with ADHD have problems that fall into both categories, but it doesn’t have to be the case. If a person just has inattentiveness it is referred to as attention deficit disorder (ADD).

Methylphenidate is a commonly used medication used to treat patients suffering from attention-deficit hyperactivity disorder. Methylphenidate is part of a group of drugs known as stimulants. Central nervous system stimulants help change the amounts of natural substances in the brain. But it is not the only intervention; others include Bupropion, exercise and CBT (Cognitive behavioural therapy).

Extensive ADHD research and case studies have been carried out over numerous years. Trip has unrivalled coverage of the evidence base including systematic reviews, clinical trials, clinical guidelines and case studies.

Studies are ongoing to assess the safety and effectiveness of stimulants used on children with ADHD and intellectual disabilities as well as in other populations and other interventions. Trip also includes ongoing controlled trials and ongoing systematic reviews (via the PROSPERO database).

Top results for adhd

141. Modafinil improves symptoms of ADHD compared with placebo in young people

Modafinil improves symptoms of ADHD compared with placebo in young people Modafinil improves symptoms of ADHD compared with placebo in young people | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username (...) * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Modafinil improves symptoms of ADHD compared with placebo in young people Article Text Therapeutics Modafinil improves symptoms of ADHD compared with placebo in young people Statistics from Altmetric.com Request Permissions If you wish to reuse

2007 Evidence-Based Mental Health

142. Methylphenidate may improve symptoms but does not increase response compared with placebo in preschool children with ADHD. (PubMed)

Methylphenidate may improve symptoms but does not increase response compared with placebo in preschool children with ADHD. 17459991 2007 05 22 2007 04 26 1362-0347 10 2 2007 May Evidence-based mental health Evid Based Ment Health Methylphenidate may improve symptoms but does not increase response compared with placebo in preschool children with ADHD. 60 Wolraich Mark L ML OU Child Study Center, Oklahoma City, Oklahoma, USA. eng Comment Journal Article England Evid Based Ment Health 100883413

2007 Evidence-Based Mental Health

143. Atomoxetine improves teacher rated symptoms in children with ADHD more than placebo

Atomoxetine improves teacher rated symptoms in children with ADHD more than placebo Atomoxetine improves teacher rated symptoms in children with ADHD more than placebo | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Atomoxetine improves teacher rated symptoms in children with ADHD more than placebo Article Text Therapeutics Atomoxetine improves teacher rated symptoms in children with ADHD more than placebo Statistics from

2007 Evidence-Based Mental Health

144. Adding multimodal behavioural therapy to methylphenidate does not improve ADHD outcomes

Adding multimodal behavioural therapy to methylphenidate does not improve ADHD outcomes Adding multimodal behavioural therapy to methylphenidate does not improve ADHD outcomes | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Adding multimodal behavioural therapy to methylphenidate does not improve ADHD outcomes Article Text Therapeutics Adding multimodal behavioural therapy to methylphenidate does not improve ADHD outcomes Statistics from

2007 Evidence-Based Mental Health

145. Should children with ADHD and normal intelligence be routinely screened for underlying cytogenetic abnormalities?

Should children with ADHD and normal intelligence be routinely screened for underlying cytogenetic abnormalities? BestBets: Should children with ADHD and normal intelligence be routinely screened for underlying cytogenetic abnormalities? Should children with ADHD and normal intelligence be routinely screened for underlying cytogenetic abnormalities? Report By: E Stephen, A D Kindley, - Specialist Registrars in Paediatrics Search checked by Bob Phillips - Section Editor, Archimedes, Archives (...) of Disease in Childhood Institution: Royal Aberdeen Children's Hospital Date Submitted: 29th September 2006 Date Completed: 2nd October 2006 Last Modified: 29th September 2006 Status: Green (complete) Three Part Question Should [children with ADHD and normal intelligence] be [routinely screened] for [underlying cytogenetic abnormalities]? Clinical Scenario You are assessing a 7 year old boy with attention and behaviour difficulties, and poor school performance. He has an average IQ and meets

2006 BestBETS

146. Modafinil improves symptoms of ADHD compared with placebo in young people. (PubMed)

Modafinil improves symptoms of ADHD compared with placebo in young people. 16868187 2006 08 11 2006 07 26 1362-0347 9 3 2006 Aug Evidence-based mental health Evid Based Ment Health Modafinil improves symptoms of ADHD compared with placebo in young people. 68 Barry Robert J RJ Brain & Behaviour Research Institute, and School of Psychology, University of Wollongong, Wollongong 2522, Australia. Clarke Adam R AR eng Comment Journal Article England Evid Based Ment Health 100883413 1362-0347

2006 Evidence-Based Mental Health

147. Adding mixed amphetamine salts to divalproex sodium improves ADHD symptoms in children with bipolar disorder and comorbid ADHD

Adding mixed amphetamine salts to divalproex sodium improves ADHD symptoms in children with bipolar disorder and comorbid ADHD Adding mixed amphetamine salts to divalproex sodium improves ADHD symptoms in children with bipolar disorder and comorbid ADHD | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log (...) in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Adding mixed amphetamine salts to divalproex sodium improves ADHD symptoms in children with bipolar disorder and comorbid ADHD Article Text

Full Text available with Trip Pro

2006 Evidence-Based Mental Health

148. Adding psychosocial therapy to methylphenidate may not improve its effectiveness in stimulant responsive children with ADHD

Adding psychosocial therapy to methylphenidate may not improve its effectiveness in stimulant responsive children with ADHD Adding psychosocial therapy to methylphenidate may not improve its effectiveness in stimulant responsive children with ADHD | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log (...) in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Adding psychosocial therapy to methylphenidate may not improve its effectiveness in stimulant responsive children with ADHD Article Text

Full Text available with Trip Pro

2006 Evidence-Based Mental Health

149. Comparing the efficacy of medications for ADHD using meta-analysis

Comparing the efficacy of medications for ADHD using meta-analysis Comparing the efficacy of medications for ADHD using meta-analysis Comparing the efficacy of medications for ADHD using meta-analysis Faraone S V, Biederman J, Spencer T J, Aleardi M CRD summary The authors concluded that the greater efficacy found for stimulants compared with nonstimulants in children with attention-deficit/hyperactivity disorder (ADHD) needs to be interpreted with caution in view of the impact of potential (...) confounding factors. There were limitations in the review process, but the authors’ conclusion appears appropriately cautious given the lack of head-to-head comparisons of different classes of ADHD drugs. Authors' objectives To compare the efficacy of drug treatments for attention-deficit/hyperactivity disorder (ADHD) in youths. Searching MEDLINE, PREMEDLINE, PubMed, ERIC, CINAHL, the Cochrane CENTRAL Register, e-psyche and Social Science Abstracts were searched for studies published after 1979

2006 DARE.

150. Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents: review of Technology Appraisal 13

Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents: review of Technology Appraisal 13 Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents: review of Technology Appraisal 13 Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents: review of Technology Appraisal 13 National (...) Institute for Health and Clinical Excellence Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation National Institute for Health and Clinical Excellence. Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents: review of Technology Appraisal 13. London: National Institute for Health and Clinical Excellence

2006 Health Technology Assessment (HTA) Database.

151. Parent involvement in treatment for ADHD: a meta-analysis of the published studies

Parent involvement in treatment for ADHD: a meta-analysis of the published studies Parent involvement in treatment for ADHD: a meta-analysis of the published studies Parent involvement in treatment for ADHD: a meta-analysis of the published studies Corcoran J, Dattalo P CRD summary This review assessed the effect of parent-involved psychosocial interventions in the treatment of children with attention deficit/hyperactivity disorder (ADHD). The authors concluded that family interventions have (...) a low to moderate effect on ADHD and externalising symptoms, but a moderate effect on child-internalising symptoms. Limitations of the analysis and uncertain quality of the included studies restrict interpretation of the results. Authors' objectives The primary objective was to determine the effect of parent-involved psychological treatment for attention deficit/hyperactivity disorder (AHDH) in children on a variety of outcomes. A secondary objective was to determine the influence of specific

2006 DARE.

152. Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents (TA98)

Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents (TA98) Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents | Guidance | NICE Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents Technology appraisal guidance [TA98] Published date: 22 March 2006 Guidance This guidance has

2006 National Institute for Health and Clinical Excellence - Technology Appraisals

153. The experiences of children and adolescents living with ADHD were reflected in 6 themes

The experiences of children and adolescents living with ADHD were reflected in 6 themes The experiences of children and adolescents living with ADHD were reflected in 6 themes | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here The experiences of children and adolescents living with ADHD were reflected in 6 themes Article Text Qualitative The experiences of children and adolescents living with ADHD were reflected in 6 themes Free Lynda W

Full Text available with Trip Pro

2005 Evidence-Based Nursing

154. Review: stimulant pharmacotherapy for children with ADHD is associated with a reduced risk of later substance abuse disorder

Review: stimulant pharmacotherapy for children with ADHD is associated with a reduced risk of later substance abuse disorder Review: stimulant pharmacotherapy for children with ADHD is associated with a reduced risk of later substance abuse disorder | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log (...) in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: stimulant pharmacotherapy for children with ADHD is associated with a reduced risk of later substance abuse disorder Article Text

Full Text available with Trip Pro

2004 Evidence-Based Medicine (Requires free registration)

155. Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies

Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies Cohen-Zion M, Ancoli-Israel S CRD summary This review assessed the effects of psychostimulants on sleep (...) in children with attention-deficit hyperactivity disorder. The authors found limited evidence to suggest a possible increase in some sleep complaints, but concluded that further studies are required. Despite some methodological limitations to this review, the authors' cautious conclusions and recommendation for further research appear reasonable. Authors' objectives To assess the relationship between attention-deficit hyperactivity disorder (ADHD) symptomatology and sleep, and the effects

2004 DARE.

156. Cost-effectiveness of methylphenidate versus AMP/DEX mixed slats for the first-line treatment of ADHD

Cost-effectiveness of methylphenidate versus AMP/DEX mixed slats for the first-line treatment of ADHD Cost-effectiveness of methylphenidate versus AMP/DEX mixed slats for the first-line treatment of ADHD Cost-effectiveness of methylphenidate versus AMP/DEX mixed slats for the first-line treatment of ADHD Narayan S, Hay J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods (...) , the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of methylphenidate (MPH) versus amphetamine/dextroamphetamine mixed salts (AMP/DEX) as first-line agents for the treatment of attention deficit hyperactivity disorder (ADHD) was studied. Type of intervention Treatment. Economic study type Cost-utility analysis. Study population The study population comprised a hypothetical cohort of male children aged

2004 NHS Economic Evaluation Database.

157. Efficacy of stimulants in adult ADHD

Efficacy of stimulants in adult ADHD Efficacy of stimulants in adult ADHD Efficacy of stimulants in adult ADHD Maidment I D CRD summary This review assessed stimulants as a treatment for adults with attention-deficit hyperactivity disorder. The quality of most of the studies was poor and there is little evidence on the effectiveness of long-term treatment. It is reasonable for the author to conclude that stimulants may be effective. Authors' objectives To assess the efficacy of stimulants (...) to treat adults with attention-deficit hyperactivity disorder (ADHD). Searching MEDLINE was searched from 1966 to 2002; the search terms were reported. The reference lists in identified articles were checked and drug manufacturers were contacted. Studies reported in English were eligible for inclusion in the review. Study selection Study designs of evaluations included in the review Eligibility criteria were not stated. The review included mostly double-blind trials of a crossover design, a few

2003 DARE.

159. Psychopharmacology and aggression - 1: a meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD.

Psychopharmacology and aggression - 1: a meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2002 DARE.

160. Effectiveness of sensory integration therapy for attention deficit hyperactivity disorder (ADHD)

Effectiveness of sensory integration therapy for attention deficit hyperactivity disorder (ADHD) Effectiveness of sensory integration therapy for attention deficit hyperactivity disorder (ADHD) Effectiveness of sensory integration therapy for attention deficit hyperactivity disorder (ADHD) Hender K Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Hender K (...) . Effectiveness of sensory integration therapy for attention deficit hyperactivity disorder (ADHD) Clayton, Victoria: Centre for Clinical Effectiveness (CCE) 2001: 7 Authors' objectives This aim of this critical appraisal was to assess the effectiveness of sensory integration therapy for attention deficit hyperactivity disorder (ADHD). Project page URL Indexing Status Subject indexing assigned by CRD MeSH Attention Deficit Disorder with Hyperactivity; Child; Occupational Therapy; Physical Therapy Modalities

2001 Health Technology Assessment (HTA) Database.